SBRA (Sabra Health Care REIT) Tariff Resilience Score: 8/10 (As of Jul. 04, 2026)


SBRA Sabra Health Care REIT Inc SBRA
78 GF Score
Price $20.16
GF Value $19.43
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Sabra Health Care REIT Tariff Resilience Score?

Sabra Health Care REIT SBRA +2.44% 78 Tariff Resilience Score is 8 as of Jul. 04, 2026. GuruFocus rates SBRA with a GF Score™ of 78/100 and a GF Value™ of $19.43 (Fairly Valued). The stock has 11 warning signs investors should review. Among 986 REITs companies, Sabra Health Care REIT ranks better than 90.57% on this metric.

Sabra Health Care REIT has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Sabra Health Care REIT has Sabra Health Care REIT Inc primarily operates in the U.S. healthcare sector, with limited exposure to international tariffs. Its revenue is largely unaffected by global trade dynamics.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Sabra Health Care REIT might have Highly Resilient.

Sabra Health Care REIT  (NAS:SBRA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Sabra Health Care REIT Tariff Resilience Score Related Terms

SBRA vs NHI, HR, MPT: Tariff Resilience Score Comparison

For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sabra Health Care REIT Tariff Resilience Score vs REITs Industry

For the REITs industry and Real Estate sector, Sabra Health Care REIT's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Sabra Health Care REIT's Tariff Resilience Score falls into.


SBRA
78GF Score
Sabra Health Care REIT Inc SBRA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Sabra Health Care REIT (SBRA) has a Tariff Resilience Score of 8 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Sabra Health Care REIT ranks #93 out of 986 companies in the REITs industry, placing it in the top 9.4%.
Is Sabra Health Care REIT's Tariff Resilience Score too high?
Sabra Health Care REIT's current Tariff Resilience Score is 8. Based on the distribution chart, Sabra Health Care REIT ranks #93 out of 986 companies in the REITs industry, which is in the top quartile — a strong position relative to peers. Overall, Sabra Health Care REIT has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's Tariff Resilience Score compare to NHI and HR?
According to the REITs industry distribution chart, Sabra Health Care REIT ranks #93 out of 986 companies for Tariff Resilience Score. This places Sabra Health Care REIT in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a REITs company?
A good Tariff Resilience Score depends on the REITs industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Sabra Health Care REIT's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (SBRA) is currently considered Fairly Valued. The stock's GF Value™ is $19.43, compared to a current price of $20.16 — trading 3.7% above its estimated fair value. The current Tariff Resilience Score is 8. Sabra Health Care REIT's overall GF Score™ is 78/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Sabra Health Care REIT (SBRA), the current Tariff Resilience Score is 8 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sabra Health Care REIT (SBRA) Overvalued in 2026?

Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be overvalued. The current stock price of $20.16 is trading 3.7% above its estimated GF Value™ of $19.43. GuruFocus considers Sabra Health Care REIT to be Fairly Valued.

Key valuation signals for SBRA:

  • Tariff Resilience Score: 8
  • GF Value™: $19.43 vs. price of $20.16 (3.7% above fair value)
  • GF Score™: 78/100 with 11 warning signs

No single metric tells the full story. See the SBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sabra Health Care REIT Business Description

Industry Real EstateREITs
Other Exchanges SBC:Germany
Address 1781 Flight Way, Tustin, CA, USA, 92782
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
78GF Score

Get the complete analysis for SBRA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.16
Price
$19.43
GF Value